JP Morgan Maintains Neutral on CME Gr, Raises Price Target to $206
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Kenneth Worthington maintains a Neutral rating on CME Group (NASDAQ:CME) and raises the price target from $198 to $206.
April 25, 2024 | 4:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan has maintained a Neutral rating on CME Group but increased the price target from $198 to $206.
The increase in price target by JP Morgan suggests a positive outlook on the stock's value, potentially leading to short-term price appreciation. However, the Neutral rating indicates that the stock might not outperform the market significantly.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100